Prenatal Cadmium Exposure and Maternal Sex Steroid Hormone Concentrations across Pregnancy
Author:
Rivera-Núñez Zorimar12ORCID, Hansel Megan1, Capurro Camila1, Kozlosky Danielle2, Wang Christina3, Doherty Cathleen L.2, Buckley Brian2, Ohman-Strickland Pamela1, Miller Richard K.45, O’Connor Thomas G.46, Aleksunes Lauren M.27ORCID, Barrett Emily S.124
Affiliation:
1. Department of Biostatistics and Epidemiology, Rutgers School of Public Health, Piscataway, NJ 08854, USA 2. Environmental and Occupational Health Sciences Institute, Rutgers University, Piscataway, NJ 08854, USA 3. Clinical and Translational Science Institute, The Lundquist Institute at Harbor-UCLA Medical Center, Torrance, CA 90502, USA 4. Department of Obstetrics and Gynecology, University of Rochester Medical Center, Rochester, NY 14620, USA 5. Department of Environmental Medicine, Pediatrics and Pathology, University of Rochester, New York, NY 14642, USA 6. Departments of Psychiatry, Psychology, Neuroscience, University of Rochester, New York, NY 14620, USA 7. Department of Pharmacology and Toxicology, Ernest Mario School of Pharmacy, Rutgers University, Piscataway, NJ 08854, USA
Abstract
Cadmium exposure has been associated with adverse perinatal outcomes. One possible mechanism is endocrine disruption. Studies of non-pregnant adults suggest that cadmium impacts androgen production; here, we examined these associations during pregnancy. Participants in the Understanding Pregnancy Signals and Infant Development (UPSIDE) cohort provided biospecimens and questionnaire data in each trimester (n = 272). We quantified urinary cadmium, serum total testosterone (TT), estrone, estradiol, and estriol and serum free testosterone (fT). In adjusted longitudinal models, we examined sex steroid concentrations across pregnancy in relation to specific gravity-adjusted, ln-transformed cadmium concentrations. Additionally, we examined trimester-specific associations and stratified models by fetal sex. Results are presented as percent change (%∆) in hormone concentrations. In longitudinal models, higher cadmium concentrations were associated with lower fT across pregnancy (%∆ = −5.19, 95%CI: −8.33, −1.93), with no differences in other hormones observed. In trimester-specific models, higher cadmium concentrations were associated with lower TT in trimester 2 (%∆ = −15.26, 95%CI: −25.15, −4.06) and lower fT in trimester 3 (%∆ = −14.35, 95%CI: −19.75, −8.59). Associations with TT were stronger in pregnancies carrying female fetuses. Maternal cadmium exposure may be associated with reduced testosterone in pregnancy. Additional work is necessary to understand how alterations in gestational testosterone activity may impact pregnancy and child health.
Funder
National Institutes of Health Wynne Center
Subject
Chemical Health and Safety,Health, Toxicology and Mutagenesis,Toxicology
Reference83 articles.
1. Faroon, O., Ashizawa, A., Wright, S., Tucker, P., Jenkins, K., Ingerman, L., and Rudisill, C. (2012). Toxicological Profile for Cadmium, Department of Health and Human Services, Public Health Service. 2. Serum Cadmium and Lead, Current Wheeze, and Lung Function in a Nationwide Study of Adults in the United States;Yang;J. Allergy Clin. Immunol. Pract.,2019 3. Cadmium Exposure and Clinical Cardiovascular Disease: A Systematic Review;Jones;Curr. Atheroscler. Rep.,2013 4. Tsai, K.-F., Hsu, P.-C., Kung, C.-T., Lee, C.-T., You, H.-L., Huang, W.-T., Li, S.-H., Cheng, F.-J., Wang, C.-C., and Lee, W.-C. (2021). The Risk Factors of Blood Cadmium Elevation in Chronic Kidney Disease. Int. J. Environ. Res. Public Health, 18. 5. Characterization of trace elements exposure in pregnant women in the United States, NHANES 1999–2016;Watson;Environ. Res.,2020
|
|